Avita Medical Receives US FDA Clearance for Wound Treatment Product

MT Newswires Live

2024/12/20

Avita Medical (ASX:AVH) received a 510(k) clearance from the US Food and Drug Administration for Cohealyx, which is used to facilitate wound healing, according to a Friday filing with the Australian bourse.

Preclinical studies in porcine models showed that Cohealyx generated strong tissue to support split-thickness skin grafts in a two-stage procedure earlier than competitors, the filing said.

The company plans to develop clinical data for Cohealyx next year for its commercial launch, according to the filing. It expects to start commercialization efforts in the US in the second quarter of 2025.

Shares rose more than 1% in morning trade Friday.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2492432002"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2492432002\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2492432002?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-20 09:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492432002","market":"sh","top_or_hot":-1,"title":"Avita Medical Receives US FDA Clearance for Wound Treatment Product","media":"MT Newswires Live","content":"<html><body><p> Avita Medical (ASX:AVH) received a 510(k) clearance from the US Food and Drug Administration for Cohealyx, which is used to facilitate wound healing, according to a Friday filing with the Australian bourse.</p><p>Preclinical studies in porcine models showed that Cohealyx generated strong tissue to support split-thickness skin grafts in a two-stage procedure earlier than competitors, the filing said.</p><p>The company plans to develop clinical data for Cohealyx next year for its commercial launch, according to the filing. It expects to start commercialization efforts in the US in the second quarter of 2025.</p><p>Shares rose more than 1% in morning trade Friday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Avita Medical Receives US FDA Clearance for Wound Treatment Product</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAvita Medical Receives US FDA Clearance for Wound Treatment Product\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-12-20 09:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Avita Medical (ASX:AVH) received a 510(k) clearance from the US Food and Drug Administration for Cohealyx, which is used to facilitate wound healing, according to a Friday filing with the Australian bourse.</p><p>Preclinical studies in porcine models showed that Cohealyx generated strong tissue to support split-thickness skin grafts in a two-stage procedure earlier than competitors, the filing said.</p><p>The company plans to develop clinical data for Cohealyx next year for its commercial launch, according to the filing. It expects to start commercialization efforts in the US in the second quarter of 2025.</p><p>Shares rose more than 1% in morning trade Friday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AVH.AU","symbol_name":"Avita Therapeutics","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2492432002","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492432002","pubTimestamp":1734657076,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Avita Medical  received a 510 clearance from the US Food and Drug Administration for Cohealyx, which is used to facilitate wound healing, according to a Friday filing with the Australian bourse.Preclinical studies in porcine models showed that Cohealyx generated strong tissue to support split-thickness skin grafts in a two-stage procedure earlier than competitors, the filing said.The company plans to develop clinical data for Cohealyx next year for its commercial launch, according to the filing. It expects to start commercialization efforts in the US in the second quarter of 2025.Shares rose more than 1% in morning trade Friday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"AVH.AU":"Avita Therapeutics","BK7508":"医药生物股","BK7067":"生物科技"},"translate_title":"阿维塔医疗伤口治疗产品获得美国FDA许可","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AVH.AU":0.9},"content_text":"Avita Medical (ASX:AVH) received a 510(k) clearance from the US Food and Drug Administration for Cohealyx, which is used to facilitate wound healing, according to a Friday filing with the Australian bourse.Preclinical studies in porcine models showed that Cohealyx generated strong tissue to support split-thickness skin grafts in a two-stage procedure earlier than competitors, the filing said.The company plans to develop clinical data for Cohealyx next year for its commercial launch, according to the filing. It expects to start commercialization efforts in the US in the second quarter of 2025.Shares rose more than 1% in morning trade Friday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}